You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 8, August 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human T-Cell Lymphotropic Virus Type III Associated Disorders

The Spectrum in the Heterosexual Population

Parkash S. Gill, MD; Alexandra M. Levine, MD; Paul R. Meyer, MD; Scott L. Aguilar, RN; Mark Rarick, MD; John W. Parker, MD; Suraiya Rasheed, PhD

Arch Intern Med. 1986;146(8):1501-1504.


Abstract

• Eleven heterosexual patients (nine women, two men) without classic risk factors for development of acquired immunodeficiency syndrome (AIDS) were seen between March 1983, and April 1985, and diagnosed as having AIDS (four), persistent, generalized lymphadenopathy (PGL) (four), or asymptomatic human T-cell lymphotropic virus type III (HTLV-III) carrier state (three). The clinical presentations and course of those with AIDS or PGL were similar to those reported in homosexual men with AIDS or PGL, with reversed T4/T8 ratio, and the presence of antibody to HTLV-III. Asymptomatic carriers had normal T4/T8 ratios, had an absence of HTLV-III antibodies, but had HTLV-III virus cultured from blood. We conclude that the heterosexual population, with or without history of sexual exposure to individuals at risk for AIDS, may develop a wide range of clinical manifestations secondary to HTLV-III, varying from AIDS to the asymptomatic carrier state.

(Arch Intern Med 1986;146:1501-1504)



Author Affiliations

From the Departments of Internal Medicine (Drs Gill, Levine, and Rarick and Mr Aguilar) and Pathology (Drs Meyer, Parker, and Rasheed), University of Southern California School of Medicine; the Kenneth Norris Jr Cancer Hospital and Research Institute (Drs Gill, Levine, Meyer, Rarick, Parker, and Rasheed and Mr Aguilar), and the Los Angeles Country-University of Southern California Medical Center (Drs Gill, Levine, Meyer, Rarick, Parker, and Rasheed and Mr Aguilar), Los Angeles.


Footnotes

Accepted for publication Nov 25, 1985.

Reprint requests to Los Angeles Country—University of Southern California Medical Center, 1200 N State St, Unit I, Room 14-442, Los Angeles, CA 90033 (Dr Gill).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.